Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-29

Clinical Trial Update: Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating neuromuscular changes in small-for-gestational-age children treated with somatropin was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GENOTROPIN (SOMATROPIN)

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Therapy, Infant, Small for Gestational Age | Phase 3 | Status: TERMINATED | Results posted: 2012-02-29